Treatment of moderate-to-severe atopic dermatitis in the elderly may be challenging, due to side effects of traditional anti-inflammatory drugs and to comorbidities often found in this age group. Furthermore, efficacy and safety of innovative drugs such as dupilumab is not yet well known.
Patruno, C., Napolitano, M., Argenziano, G., Peris, K., Ortoncelli, M., Girolomoni, G., et al. (2020). Dupilumab therapy of atopic dermatitis of the elderly: a multi-centre, real-life study. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY [10.1111/jdv.17094].
Dupilumab therapy of atopic dermatitis of the elderly: a multi-centre, real-life study
Talamonti, M;
2020-12-17
Abstract
Treatment of moderate-to-severe atopic dermatitis in the elderly may be challenging, due to side effects of traditional anti-inflammatory drugs and to comorbidities often found in this age group. Furthermore, efficacy and safety of innovative drugs such as dupilumab is not yet well known.File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
DUPILUMAB THERAPY OF ATOPIC DERMATITIS OF THE ELDERLY.pdf
solo utenti autorizzati
Tipologia:
Documento in Post-print
Licenza:
Copyright dell'editore
Dimensione
592.52 kB
Formato
Adobe PDF
|
592.52 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.